![JCM | Free Full-Text | Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients JCM | Free Full-Text | Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients](https://www.mdpi.com/jcm/jcm-08-00388/article_deploy/html/images/jcm-08-00388-g001.png)
JCM | Free Full-Text | Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients
Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors | Organic Process Research & Development
![Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions | Journal of Medicinal Chemistry Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01070/asset/images/large/jm2c01070_0016.jpeg)
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions | Journal of Medicinal Chemistry
![Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate | Journal of Medicinal Chemistry Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm100262j/asset/images/large/jm-2010-00262j_0012.jpeg)
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate | Journal of Medicinal Chemistry
![PDF) Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients PDF) Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients](https://i1.rgstatic.net/publication/331904117_Differential_Responses_of_Colorectal_Cancer_Cell_Lines_to_Enterococcus_faecalis'_Strains_Isolated_from_Healthy_Donors_and_Colorectal_Cancer_Patients/links/5fbcb17f458515b797642299/largepreview.png)
PDF) Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients
![PDF) Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy PDF) Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy](https://i1.rgstatic.net/publication/358590599_Effects_of_viremia_and_CD4_recovery_on_gut_microbiome-immunity_axis_in_treatment-naive_HIV-1-infected_patients_undergoing_antiretroviral_therapy/links/6380d62148124c2bc66c377a/largepreview.png)
PDF) Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy
![Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer | Journal of Medicinal Chemistry Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b01355/asset/images/large/jm-2016-01355m_0019.jpeg)
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer | Journal of Medicinal Chemistry
![Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate | Journal of Medicinal Chemistry Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm100262j/asset/images/large/jm-2010-00262j_0001.jpeg)